Pancreatic cancer vaccine prevents recurrence in Phase 1 clinical trial

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back. Pancreatic cancer is of particular concern . The five-year survival rate is about 13% , and up to 80% of pancreatic cancers may come back .